As of 2026-10-05, the EV/EBITDA ratio of Arena Pharmaceuticals Inc (ARNA) is -10.98. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ARNA's latest enterprise value is 5,982.02 mil USD. ARNA's TTM EBITDA according to its financial statements is -545.06 mil USD. Dividing these 2 quantities gives us the above ARNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.9x - 15.6x | 14.2x |
| Forward P/E multiples | 16.4x - 20.3x | 18.4x |
| Fair Price | (142.35) - (134.93) | (140.67) |
| Upside | -242.4% - -234.9% | -240.7% |
| Date | EV/EBITDA |